We are live on ! Find out more
MCM

Mengis Capital Management Portfolio holdings

AUM $581M
1-Year Est. Return 28.04%
This Fund
S&P 500
This Quarter Est. Return
+17.95%
1 Year Est. Return
+28.04%
3 Year Est. Return
+72.9%
5 Year Est. Return
+105.39%
10 Year Est. Return
+334.2%
AUM
$337M
AUM Growth
+$44M
Cap. Flow
-$2.63M
Cap. Flow %
-0.78%
Top 10 Hldgs %
37.16%
Holding
162
New
3
Increased
55
Reduced
58
Closed
7

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$741K
2
MRK icon
Merck
MRK
+$540K
3
IAU icon
iShares Gold Trust
IAU
+$346K
4
JPM icon
JPMorgan Chase
JPM
+$269K
5
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$268K

Top Sells

Rank Stock Value
1
SCHO icon
Schwab Short-Term US Treasury ETF
SCHO
+$1.15M
2
PRU icon
Prudential Financial
PRU
+$866K
3
AMD icon
Advanced Micro Devices
AMD
+$570K
4
AGN
Allergan plc
AGN
+$521K
5
GBIL icon
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
+$453K

Sector Composition

Rank Sector Weight
1 Technology 22.52%
2 Healthcare 17.43%
3 Industrials 15.19%
4 Consumer Staples 8.47%
5 Financials 5.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.88T
$27.8M 8.26%
304,932
-3,956
-1% -$307K
MSFT icon
2
Microsoft
MSFT
$2.85T
$22.3M 6.64%
109,794
-548
-0.5% -$99.5K
PCAR icon
3
PACCAR
PCAR
$69.8B
$21.5M 6.38%
430,307
– –
COST icon
4
Costco
COST
$414B
$9.24M 2.74%
30,468
-50
-0.2% -$15.2K
JNJ icon
5
Johnson & Johnson
JNJ
$634B
$7.79M 2.31%
55,371
+452
+0.8% +$65.9K
INTC icon
6
Intel
INTC
$470B
$7.76M 2.3%
129,647
+385
+0.3% +$23K
MRK icon
7
Merck
MRK
$325B
$7.43M 2.21%
100,678
+7,168
+8% +$540K
GSIE icon
8
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.86B
$7.4M 2.2%
278,435
-1,304
-0.5% -$32.8K
BMY icon
9
Bristol-Myers Squibb
BMY
$127B
$7.27M 2.16%
123,659
+12,384
+11% +$741K
GOOG icon
10
Alphabet (Google) Class C
GOOG
$3.9T
$6.64M 1.97%
93,980
+680
+0.7% +$45.9K
NVS icon
11
Novartis
NVS
$295B
$6.3M 1.87%
72,092
+22
+0% +$1.9K
HD icon
12
Home Depot
HD
$331B
$6.01M 1.79%
24,011
– –
DE icon
13
Deere & Co
DE
$168B
$5.74M 1.71%
36,548
– –
QCOM icon
14
Qualcomm
QCOM
$176B
$5.5M 1.63%
60,303
-220
-0.4% -$17.6K
JPM icon
15
JPMorgan Chase
JPM
$937B
$5.42M 1.61%
57,640
+2,840
+5% +$269K
BIIB icon
16
Biogen
BIIB
$29.9B
$4.78M 1.42%
17,850
+11
+0.1% +$3.31K
CVX icon
17
Chevron
CVX
$389B
$4.51M 1.34%
50,518
+735
+1% +$65.8K
PEP icon
18
PepsiCo
PEP
$187B
$4.41M 1.31%
33,320
+5
+0% +$659
VZ icon
19
Verizon
VZ
$192B
$4.32M 1.28%
78,393
+3,202
+4% +$180K
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
$4.07M 1.21%
95,953
-5,718
-6% -$243K
WWD icon
21
Woodward
WWD
$24.8B
$3.81M 1.13%
49,137
– –
IBM icon
22
IBM
IBM
$203B
$3.76M 1.12%
32,603
+5
+0% +$581
CVS icon
23
CVS Health
CVS
$137B
$3.65M 1.08%
56,219
+2,505
+5% +$158K
FLIR
24
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$3.54M 1.05%
87,234
+6,385
+8% +$265K
AMZN icon
25
Amazon
AMZN
$2.49T
$3.47M 1.03%
25,160
+840
+3% +$101K
1
2 3 4 5

Similar funds

TCM
Trybe Capital Management Greenwich, Connecticut $581M AUM 112.96% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
TCMX
Technology Crossover Management XI Menlo Park, California $582M AUM 17.87% 1-Year Est. Return
DLCIG
D.L. Carlson Investment Group Concord, New Hampshire $582M AUM 29.47% 1-Year Est. Return
GF
Goodman Financial Houston, Texas $582M AUM 22.09% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Mengis Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Mengis Capital Management held 162 positions worth $337M, up 15% from $293M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Mengis Capital Management's Q2 2020 filing shows 3 new, 55 increased, 58 reduced and 7 closed positions. Its largest new stake was Vanguard Dividend Appreciation ETF: 2,353 shares worth $275K. The largest sale was Schwab Short-Term US Treasury ETF, an estimated $1.15M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Mengis Capital Management's largest Q2 2020 buy was Vanguard Dividend Appreciation ETF: 2,353 shares worth $275K.
  • Mengis Capital Management added most to Bristol-Myers Squibb in Q2 2020, an estimated $741K increase.
  • Mengis Capital Management's biggest Q2 2020 reduction was Schwab Short-Term US Treasury ETF, cutting an estimated $1.15M.
  • Mengis Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $521K.
  • Mengis Capital Management's ten largest holdings make up 37% of its $337M portfolio in Q2 2020.
  • Mengis Capital Management opened 3 new positions and closed 7 in Q2 2020.
  • Mengis Capital Management's portfolio value rose 15% quarter-over-quarter to $337M.

Based on Mengis Capital Management's 13F filing for Q2 2020, filed 22 Jul 2020.